Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

589 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hybrid Close-Loop Systems Versus Predictive Low-Glucose Suspend and Sensor-Augmented Pump Therapy in Patients With Type 1 Diabetes: A Single-Center Cohort Study.
Lunati ME, Morpurgo PS, Rossi A, Gandolfi A, Cogliati I, Bolla AM, Plebani L, Vallone L, Montefusco L, Pastore I, Cimino V, Argenti S, Volpi G, Zuccotti GV, Fiorina P. Lunati ME, et al. Among authors: zuccotti gv. Front Endocrinol (Lausanne). 2022 Apr 14;13:816599. doi: 10.3389/fendo.2022.816599. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35498423 Free PMC article.
Use of integrated real-time continuous glucose monitoring/insulin pump system in children and adolescents with type 1 diabetes: a 3-year follow-up study.
Scaramuzza AE, Iafusco D, Rabbone I, Bonfanti R, Lombardo F, Schiaffini R, Buono P, Toni S, Cherubini V, Zuccotti GV; Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology. Scaramuzza AE, et al. Among authors: zuccotti gv. Diabetes Technol Ther. 2011 Feb;13(2):99-103. doi: 10.1089/dia.2010.0119. Diabetes Technol Ther. 2011. PMID: 21284475
Sensor-augmented pump therapy in very young children with type 1 diabetes: an efficacy and feasibility observational study.
Frontino G, Bonfanti R, Scaramuzza A, Rabbone I, Meschi F, Rigamonti A, Battaglino R, Favalli V, Bonura C, Sicignano S, Gioia E, Zuccotti GV, Cerutti F, Chiumello G. Frontino G, et al. Among authors: zuccotti gv. Diabetes Technol Ther. 2012 Sep;14(9):762-4. doi: 10.1089/dia.2012.0044. Epub 2012 Jun 13. Diabetes Technol Ther. 2012. PMID: 22694194
Explaining the increased mortality in type 1 diabetes.
Mameli C, Mazzantini S, Ben Nasr M, Fiorina P, Scaramuzza AE, Zuccotti GV. Mameli C, et al. Among authors: zuccotti gv. World J Diabetes. 2015 Jul 10;6(7):889-95. doi: 10.4239/wjd.v6.i7.889. World J Diabetes. 2015. PMID: 26185597 Free PMC article.
Immunoevasion rather than intrinsic oncogenicity may confer MSCs from non-obese diabetic mice the ability to generate neural tumors.
Loretelli C, Moore RF, Ben Nasr M, Dellepiane S, Balan M, Mounayar M, Usuelli V, El Essawy B, D'Addio F, Stemmer-Rachamimov AO, Zuccotti GV, Pal S, Fiorina P, Abdi R. Loretelli C, et al. Among authors: zuccotti gv. Acta Diabetol. 2017 Jul;54(7):707-712. doi: 10.1007/s00592-017-0967-0. Epub 2017 Feb 21. Acta Diabetol. 2017. PMID: 28224274 No abstract available.
Immunotherapy for type 1 diabetes.
Frumento D, Ben Nasr M, El Essawy B, D'Addio F, Zuccotti GV, Fiorina P. Frumento D, et al. Among authors: zuccotti gv. J Endocrinol Invest. 2017 Aug;40(8):803-814. doi: 10.1007/s40618-017-0641-y. Epub 2017 Mar 4. J Endocrinol Invest. 2017. PMID: 28260183 Review.
PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes.
Ben Nasr M, Tezza S, D'Addio F, Mameli C, Usuelli V, Maestroni A, Corradi D, Belletti S, Albarello L, Becchi G, Fadini GP, Schuetz C, Markmann J, Wasserfall C, Zon L, Zuccotti GV, Fiorina P. Ben Nasr M, et al. Among authors: zuccotti gv. Sci Transl Med. 2017 Nov 15;9(416):eaam7543. doi: 10.1126/scitranslmed.aam7543. Sci Transl Med. 2017. PMID: 29141886 Free PMC article.
589 results